Advances in screening of thalassaemia

Jie Gao,Wenjun Liu,Jie Gao,Wenjun Liu
DOI: https://doi.org/10.1016/j.cca.2022.08.001
IF: 6.314
2022-09-01
Clinica Chimica Acta
Abstract:Thalassaemia is a common hereditary haemolytic anaemia. Mild cases of this disease may be asymptomatic, while patients with severe thalassaemias require high-dose blood transfusions and regular iron removal to maintain life or haematopoietic stem cell transplantation to be cured, imposing an enormous familial and social burden. Therefore, early, timely, and accurate screening of patients is of great importance. In recent years, with the continuous development of thalassaemia screening technologies, the accuracy of thalassaemia screening has also improved significantly. This article reviews the current research on thalassaemia screening.
medical laboratory technology
What problem does this paper attempt to address?